Mimotope Vaccines against Tumor Antigens
A Strategy for Active Immunotherapy?
(Sprache: Englisch)
Cancer is an important public health concern since it is the second leading cause of death in the developed world. Previous treatments, such as surgical tumor resection, radio- or chemotherapy also harm healthy tissue and, therefore, are limited by these...
Leider schon ausverkauft
versandkostenfrei
Buch (Kartoniert)
49.00 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „Mimotope Vaccines against Tumor Antigens “
Klappentext zu „Mimotope Vaccines against Tumor Antigens “
Cancer is an important public health concern since it is the second leading cause of death in the developed world. Previous treatments, such as surgical tumor resection, radio- or chemotherapy also harm healthy tissue and, therefore, are limited by these adverse effects. In contrast, immunotherapy using the endogenous defense mechanisms poses a specific, nontoxic and mild therapy. But how can we approach this advantageous new therapy? This book gives us an introductory review of the role of the immune system in recognition and prevention of cancer as well as of current research strategies. Furthermore, the author provides a detailed guide for creating so called mimotopes for the carcinoembryonic antigen (CEA), which is a possible basis for establishing active immunotherapy, i.e. cancer vaccination.This book is mainly directed at PhD students and young scientists interested in oncology.
Autoren-Porträt von Agnes Boltz
Boltz, AgnesAgnes Boltz studies at the Medical University of Vienna and performed the research for this book at the Department of Pathophysiology from 2005 to 2007.
Bibliographische Angaben
- Autor: Agnes Boltz
- 2008, 60 Seiten, Maße: 15 x 22 cm, Kartoniert (TB), Englisch
- Verlag: VDM Verlag Dr. Müller e.K.
- ISBN-10: 3639043758
- ISBN-13: 9783639043754
Sprache:
Englisch
Kommentar zu "Mimotope Vaccines against Tumor Antigens"
Schreiben Sie einen Kommentar zu "Mimotope Vaccines against Tumor Antigens".
Kommentar verfassen